Poole CD - Search Results

1

Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality.

Currie CJ, Poole CD, Conway P. Currie CJ, et al. Among authors: poole cd. Heart. 2008 Apr;94(4):457-62. doi: 10.1136/hrt.2007.118794. Epub 2007 Aug 29. Heart. 2008. PMID: 17761503

2

An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice.

Poole CD, Conway P, Currie CJ. Poole CD, et al. Rheumatology (Oxford). 2009 Jan;48(1):78-82. doi: 10.1093/rheumatology/ken415. Rheumatology (Oxford). 2009. PMID: 19056800

3

An evaluation of the association between systemic inflammation--as measured by C-reactive protein--and hospital resource use.

Poole CD, Conway P, Currie CJ. Poole CD, et al. Curr Med Res Opin. 2007 Nov;23(11):2785-92. doi: 10.1185/030079907x233205. Curr Med Res Opin. 2007. PMID: 17908371

4

Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications.

Morgan CL, McEwan P, Morrissey M, Peters JR, Poole C, Currie CJ. Morgan CL, et al. Diabet Med. 2006 Oct;23(10):1100-5. doi: 10.1111/j.1464-5491.2006.01936.x. Diabet Med. 2006. PMID: 16978374

5

The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy.

Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, Covington MT, Peters JR. Currie CJ, et al. Among authors: poole cd. Diabet Med. 2007 Feb;24(2):187-94. doi: 10.1111/j.1464-5491.2006.02057.x. Diabet Med. 2007. PMID: 17257282

6

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Currie CJ, Poole CD, Gale EA. Currie CJ, et al. Among authors: poole cd. Diabetologia. 2009 Sep;52(9):1766-77. doi: 10.1007/s00125-009-1440-6. Epub 2009 Jul 2. Diabetologia. 2009. PMID: 19572116

7

Poole CD, Chambers C, Sidhu MK, Currie CJ. Poole CD, et al. Br J Dermatol. 2009 Dec;161(6):1335-40. doi: 10.1111/j.1365-2133.2009.09379.x. Epub 2009 Jul 1. Br J Dermatol. 2009. PMID: 19754867 Clinical Trial.

8

Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*.

Currie CJ, Gale EA, Poole CD. Currie CJ, et al. Among authors: poole cd. Diabet Med. 2010 Aug;27(8):938-48. doi: 10.1111/j.1464-5491.2010.03040.x. Diabet Med. 2010. PMID: 20653753

9

Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs.

Morgan CL, Jenkins-Jones S, Evans M, Barnett AH, Poole CD, Currie CJ. Morgan CL, et al. Among authors: poole cd. Diabetes Obes Metab. 2012 May;14(5):424-32. doi: 10.1111/j.1463-1326.2011.01552.x. Epub 2012 Jan 17. Diabetes Obes Metab. 2012. PMID: 22192841

10

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010.

Holden SH, Barnett AH, Peters JR, Jenkins-Jones S, Poole CD, Morgan CL, Currie CJ. Holden SH, et al. Among authors: poole cd. Diabetes Obes Metab. 2013 Sep;15(9):844-52. doi: 10.1111/dom.12123. Epub 2013 May 16. Diabetes Obes Metab. 2013. PMID: 23675742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters